BioPharma Today

Editors' Picks From The World Press

Business & Finance

Execs, regulators, pioneers on biotech most-influential list
FierceBiotech Feb. 7, 2012

Editor's Picks from the World Press

Business & Finance

Alexion finalizes acquisition of Enobia for $1.1 billion
The Hartford Courant (Conn.) Feb. 8, 2012

Editor's Picks From The World Press

Business & Finance

Survey: Biopharma execs are concerned with the "value challenge"
PharmaTimes (U.K.) Feb. 7, 2012, PMLive.com (U.K.) Feb. 7, 2012

Illumina officially rejects Roche's $5.7 billion offer
Reuters Feb. 7, 2012, The New York Times (tiered subscription model) Feb. 7, 2012

Government & Legal News

NIH to boost Alzheimer's research funding; Obama to request more
Yahoo! Feb. 7, 2012

Wash. bill for medication disposal faces industry opposition
The Seattle Times Feb. 7, 2012

Judge sides with FDA on approving generic of Sanofi's Lovenox
The Wall Street Journal Feb. 7, 2012

Pfizer and Ranbaxy delayed generic Lipitor, lawsuit says
Bloomberg Feb. 6, 2012

FDA approves Shire's Vyvanse capsule for adult ADHD
Drug Store News Feb. 7, 2012

FDA accelerates review of Genentech breast cancer drug
American City Business Journals Feb. 7, 2012

FDA voices doubt about Qutenza's efficacy for HIV-related pain
Bloomberg Feb. 7, 2012

FDA denies ViroPharma's plan to increase production of Cinryze
American City Business Journals Feb. 7, 2012

Pipeline/R&D News

GSK halts enrollment in 4 trials of anti-infective agent
The Wall Street Journal Feb. 6, 2012

Trial of Merck's anti-coagulant vorapaxar yields mixed results
Reuters Feb. 7, 2012, The Wall Street Journal Feb. 7, 2012

Editors' Picks From The World Press

Business & Finance

Genoscience and RFS license hepatitis C candidate to BioLineRx
Genetic Engineering & Biotechnology News Feb. 6, 2012

Editors' Picks From The World Press

Business & Finance

AstraZeneca plans to cut jobs as drug patents expire
Reuters Feb. 2, 2012

Editor's Picks from the World Press

Business & Finance

Impax obtains U.S. rights to AstraZeneca's migraine drug Zomig
Fox Business Feb. 1, 2012

Editors' Picks From The World Press

Business & Finance

Landmark drug deal targets tropical diseases
The Guardian (London) Jan. 30, 2012

Editors' Picks From The World Press

Business & Finance

Drugmakers made fewer licensing deals in 2011
PharmaTimes (U.K.) Jan. 26, 2012

Editor's Picks from the World Press

Business & Finance

Roche offers $5.7 billion to acquire Illumina
The Telegraph (London) Jan. 25, 2012

Editor's Picks From The World Press

Business & Finance

Ascent is acquired by Watson for about $393 million
PharmaTimes (U.K.) Jan. 24, 2012

Lilly and Jubilant reportedly end molecule venture
The Economic Times (India) Jan. 25, 2012

Ipsen gives fipamezole rights back to Santhera
Reuters Jan. 24, 2012

BioLineRx licenses Genoscience's hepatitis C drug candidate
Genetic Engineering & Biotechnology News Jan. 24, 2012

Investors and drugmakers eye orphan-disease market
Bloomberg Jan. 23, 2012

Government & Legal News

Poll: FDA receives high marks for drug approval
Genetic Engineering & Biotechnology News Jan. 24, 2012

United Therapeutics' Remodulin faces generic challenge, FDA says
Bloomberg Jan. 24, 2012

Canada warns about mixing aliskiren with other anti-hypertensives
The Toronto Star Jan. 24, 2012

MorphoSys obtains patent for cancer drug candidate
Pharmaceutical Business Review Online Jan. 23, 2012

Court rules against J&J in patent case for drug-coated stents
The Wall Street Journal Jan. 23, 2012

Pipeline/R&D News

Drug for enlarged prostate shows promise against cancer
The New York Times (tiered subscription model) Jan. 23, 2012

Embryonic stem cells improve failing vision in study
CNN Jan. 24, 2012, The Washington Post Jan. 23, 2012